Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 12:13 pm Sale | 2024-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | EVENTIDE ASSET MANAGEMENT LLC | 4,475,054 6.280% | -2,615,054 (-36.88%) | Filing History |
| 2025-02-14 12:11 pm Sale | 2024-12-31 | 13G | Xometry, Inc. XMTR | EVENTIDE ASSET MANAGEMENT LLC | 3,151,897 6.720% | -1,266,767 (-28.67%) | Filing History |
| 2025-02-14 12:08 pm Sale | 2024-12-31 | 13G | Nektar Therapeutics NKTR | EVENTIDE ASSET MANAGEMENT LLC | 6,650,000 3.610% | -2,750,000 (-29.26%) | Filing History |
| 2025-02-14 12:06 pm Sale | 2024-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | EVENTIDE ASSET MANAGEMENT LLC | 2,606,938 5.430% | -838,425 (-24.33%) | Filing History |
| 2025-02-14 12:03 pm Sale | 2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | EVENTIDE ASSET MANAGEMENT LLC | 1,234,834 3.730% | -621,152 (-33.47%) | Filing History |
| 2025-02-14 12:01 pm Purchase | 2024-12-31 | 13G | Inozyme Pharma, Inc. INZY | EVENTIDE ASSET MANAGEMENT LLC | 2,220,000 3.460% | 2,220,000 (New Position) | Filing History |
| 2025-02-14 11:56 am Sale | 2024-12-31 | 13G | Aura Biosciences, Inc. AURA | EVENTIDE ASSET MANAGEMENT LLC | 4,080,605 8.170% | -1,722,077 (-29.68%) | Filing History |
| 2025-02-05 5:59 pm Purchase | 2025-01-31 | 13G | Beta Bionics, Inc. BBNX | EVENTIDE ASSET MANAGEMENT LLC | 4,857,041 11.320% | 4,857,041 (New Position) | Filing History |
| 2024-11-14 12:27 pm Sale | 2024-09-30 | 13G | Xometry, Inc. XMTR | EVENTIDE ASSET MANAGEMENT LLC | 4,418,664 9.480% | -1,309,106 (-22.86%) | Filing History |
| 2024-11-14 12:25 pm Purchase | 2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM | EVENTIDE ASSET MANAGEMENT LLC | 3,445,363 7.220% | 751,782 (+27.91%) | Filing History |
| 2024-11-14 12:24 pm Sale | 2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | -4,529,997 (Position Closed) | Filing History |
| 2024-11-14 12:23 pm Sale | 2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | EVENTIDE ASSET MANAGEMENT LLC | 1,855,986 5.610% | -336,225 (-15.34%) | Filing History |
| 2024-11-14 12:21 pm Sale | 2024-09-30 | 13G | Korro Bio, Inc. KRRO | EVENTIDE ASSET MANAGEMENT LLC | 391,166 4.210% | -155,159 (-28.40%) | Filing History |
| 2024-11-14 12:19 pm Purchase | 2024-09-30 | 13G | Inozyme Pharma, Inc. INZY | EVENTIDE ASSET MANAGEMENT LLC | 4,134,436 6.440% | 954,599 (+30.02%) | Filing History |
| 2024-11-14 12:18 pm Sale | 2024-09-30 | 13G | Celldex Therapeutics, Inc. CLDX | EVENTIDE ASSET MANAGEMENT LLC | 3,332,005 5.030% | -298,008 (-8.21%) | Filing History |
| 2024-11-14 12:17 pm Purchase | 2024-09-30 | 13G | Nektar Therapeutics NKTR | EVENTIDE ASSET MANAGEMENT LLC | 9,400,000 5.110% | 9,400,000 (New Position) | Filing History |
| 2024-11-06 2:47 pm Sale | 2024-10-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | EVENTIDE ASSET MANAGEMENT LLC | 7,090,108 9.970% | -4,469,867 (-38.67%) | Filing History |
| 2024-08-09 09:43 am Sale | 2024-07-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | EVENTIDE ASSET MANAGEMENT LLC | 2,192,211 6.650% | -810,620 (-27.00%) | Filing History |
| 2024-02-14 12:49 pm Purchase | 2023-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | EVENTIDE ASSET MANAGEMENT LLC | 2,693,581 5.780% | 636,581 (+30.95%) | Filing History |
| 2024-02-14 12:43 pm Sale | 2023-12-31 | 13G | Annexon, Inc. ANNX | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | -3,626,508 (Position Closed) | Filing History |